BioCentury
ARTICLE | Company News

StemCells neurology, gene/cell therapy news

January 4, 2016 8:00 AM UTC

StemCells will reduce headcount by 17 (about 23%) to 57 to focus resources on developing human neural stem cells (HuCNS-SC) to treat chronic spinal cord injury (SCI). The cuts will come from its U.S.-...